Atrial flutter-related health care use and costs: An analysis of a nationally representative administrative claims database in the United States

被引:0
|
作者
Deshmukh, Abhishek [1 ]
Iglesias, Maximiliano [2 ]
Khanna, Rahul [3 ,4 ]
Beaulieu, Tara [3 ]
机构
[1] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA
[2] Johnson & Johnson Med Devices, Franchise Hlth Econ & Market Access, Irvine, CA USA
[3] Johnson & Johnson, MedTech Epidemiol & Real World Data Sci, New Brunswick, NJ USA
[4] Johnson & Johnson, MedTech Epidemiol & Real World Data Sci, 410 George St, New Brunswick, NJ 08901 USA
来源
HEART RHYTHM O2 | 2023年 / 4卷 / 06期
关键词
Arrhythmia; Atrial flutter; Cost burden; Health care use burden; United States; FIBRILLATION; PREVALENCE; MORTALITY; ABLATION; BURDEN;
D O I
10.1016/j.hroo.2023.04.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Atrial flutter (AFL) is a common arrhythmia associ-ated with significant morbidity, yet the incremental burden of this condition has not been well documented. OBJECTIVE Using real-world data, we sought to evaluate the healthcare use and cost burden of incident AFL in the United States METHODS From 2017 to 2020, persons with an incident diagnosis of AFL were identified through Optum Clinformatics, a nationally representative administrative claims database of commercially insured individuals in the United States. We constructed 2 cohorts (AFL patient; non-AFL comparator) and used a matching weights method to balance covariates between cohorts. Using logistic regression and general linear models, 12-month all-cause and car-diovascular (CV)-related health care use (inpatient, outpatient, emergency room [ER] visits, and other) as well as medical expendi-tures were compared between the matched cohorts. RESULTS The matching weight sample sizes were 13,270 for AFL and 13,683 for the non-AFL cohorts. In the AFL cohort, w71% were at least 70 years of age, 62% identified as male, and 78% iden-tified as White. The AFL cohort had significantly higher health care use, including all-cause (relative risk [RR] 1.14; 95% confidence in-terval [CI] 1.11-1.18) and CV-related ER visits (RR 1.60; 95% CI 1.52-1.70) compared with the non-AFL cohort. Mean total health care costs (per patient annually) were almost $21,783 (95% CI $18,967-$24,599) higher among patients with AFL compared to those without AFL ($71,201 vs $49,418, respectively; P ,.001). CONCLUSION Amidst the backdrop of an aging population, find-ings from this study draw attention to the importance of timely and adequate treatment of AFL.
引用
收藏
页码:367 / 373
页数:7
相关论文
共 50 条
  • [21] Retrospective health care claims database analysis of direct medical costs of newly diagnosed patients (pts) with hepatocellular carcinoma (HCC) in the United States
    Poklepovic, A. S.
    Sanyal, A.
    Moyneur, E.
    Meyers, S.
    Barghout, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Predictors of health care outcomes and costs related to medication use in patients with acne in the United States
    Balkrishnan, R
    Kulkarni, A
    Cayce, K
    Feldman, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB20 - AB20
  • [23] Predictors of health care outcomes and costs related to medication use in patients with acne in the United States
    Balkrishnan, R
    Kulkarni, A
    Feldman, S
    VALUE IN HEALTH, 2005, 8 (06) : A146 - A146
  • [24] HEALTH CARE RESOURCE USE AND MEDICAL COSTS ATTRIBUTABLE TO RESPIRATORY SYNCYTIAL VIRUS (RSV) AMONG ADULTS ≥60 YEARS OF AGE IN THE UNITED STATES: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS
    Aris, E.
    Brabant, Y.
    La, E. M.
    Candrilli, S.
    Molnar, D.
    VALUE IN HEALTH, 2023, 26 (06) : S124 - S124
  • [25] FIRST AND SECOND LINE LUNG CANCER TREATMENT UTILIZATION PATTERNS AND ASSOCIATED COSTS IN A UNITED STATES HEALTH CARE CLAIMS DATABASE
    Ramsey, S.
    Henk, H.
    Sullivan, J.
    Teitelbaum, A.
    Akhras, K.
    Sollano, J.
    Smith, G.
    Chen, C.
    VALUE IN HEALTH, 2011, 14 (07) : A442 - A443
  • [26] ADMINISTRATIVE COSTS IN THE UNITED-STATES HEALTH-CARE SYSTEM - THE PROBLEM OF THE SOLUTION
    GAUTHIER, AK
    ROGAL, DL
    BARRAND, NL
    COHEN, AB
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 1992, 29 (03) : 308 - 320
  • [27] Comparing oral health care utilization estimates in the United States across three nationally representative surveys
    Macek, MD
    Manski, RJ
    Vargas, CM
    Moeller, JF
    HEALTH SERVICES RESEARCH, 2002, 37 (02) : 499 - 521
  • [28] Vismodegib Use in Clinical Practice: Analysis of a United States Medical Claims Database
    Hanke, C. William
    Mhatre, Shivani K.
    Oliveri, David
    Zivkovic, Marko
    Caro, Ivor
    Bergstrom, Daniel
    Dawson, Keith
    Sima, Camelia S.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (02) : 143 - 148
  • [29] Billing and insurance-related administrative costs in United States' health care: synthesis of micro-costing evidence
    Jiwani, Aliya
    Himmelstein, David
    Woolhandler, Steffie
    Kahn, James G.
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [30] Billing and insurance-related administrative costs in United States’ health care: synthesis of micro-costing evidence
    Aliya Jiwani
    David Himmelstein
    Steffie Woolhandler
    James G Kahn
    BMC Health Services Research, 14